ChartRow logo
BMY
Bristol-Myers Squibb CompanyStock · Healthcare · S&P 500 0.2%
$66.05+$1.42 (+2.20%)as of market close, Aug 18, 2026
☾ After hours:$66.05+0.00%3:59 PM ET
CompareLLYUNHJNJISRGABBVTMO

BMY financial statements

The full income statement, balance sheet, and cash-flow statement for Bristol-Myers Squibb Company (BMY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 2.03B2024-09 2.03B2024-12 2.03B2025-03 2.04B2025-06 2.04B2025-09 2.04B2025-12 2.04B2026-03 2.04B2026-06 2.04B+0.8% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

About this data

Source: BMY's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BMY filings on SEC EDGAR → Not investment advice.